Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction. [electronic resource]
- Circulation May 1994
- 1982-91 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0009-7322
10.1161/01.cir.89.5.1982 doi
Angioplasty, Balloon, Coronary Electrocardiography, Ambulatory Female Gated Blood-Pool Imaging Humans Male Middle Aged Myocardial Infarction--diagnosis Myocardial Reperfusion Injury--diagnosis Recombinant Proteins--therapeutic use Superoxide Dismutase--therapeutic use Ventricular Function, Left--drug effects